MMMaria Masid

Maria Masid

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Maria Masid has a total of 86 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Computational Inference of Metabolic Programs: A Case Study Analyzing the Effect of BRCA1 Loss

    by Maria Masid, Ioanna A. Rota, David Barras, Flavia De Carlo, Pierpaolo Ginefra, Mathieu Desbuisson, Yaquelin Ortiz-Miranda, Dmitriy Zamarin, Sohrab P. Shah, Nicola Vannini, et al.

    SUMMARY: Metabolic reprogramming is a hallmark of cancer, yet how oncogenic drivers shape tumor metabolism across disease progression remains incompletely understood. In this study, we present iMSEA ( in silico Metabolic State and Enrichment Analysis), a computational framework that infers flux-based metabolic states from omics profiles. Applying iMSEA to isogenic BRCA1 -mutant and BRCA1 -wild-type ovarian cancer cells, we identified a shift toward glycolysis, nucleotide biosynthesis, and redox imbalance, coupled with impaired oxidative phosphorylation. These predictions were validated with metabolomics, Seahorse, and SCENITH assays, demonstrating the accuracy of our approach. Extending the analysis to homologous recombination deficient patient tumors at single-cell resolution, we found that BRCA1-deficient cancers display heightened metabolic activity and site-specific adaptations, including altered central carbon fluxes, mitochondrial function, nucleotide biosynthesis, and lipid metabolism. By linking transcriptional programs to functional metabolic states, iMSEA reveals hidden metabolic liabilities in BRCA1-deficient ovarian cancer and provides a broadly applicable strategy for dissecting metabolic heterogeneity and therapeutic vulnerabilities in cancer.


  • Open Access

    Multi-omics-driven kinetic modeling reveals metabolic adaptations and vulnerabilities in BRCA1-deficient ovarian cancer

    by Ilias Toumpe, Maria Masid, Vassily Hatzimanikatis, Ljubisa Miskovic

    BRCA1 -deficient ovarian cancer cells undergo extensive metabolic reprogramming, yet the network-level dynamics underlying their proliferation and treatment response remain poorly resolved. Here, we construct large-scale multi-omics-driven kinetic model populations of ovarian cancer metabolism to track how tumor cells adapt to changes in nutrient use, energy production, and metabolite dynamics over time. Across BRCA1 wild-type and mutant cells, these models expose distinct metabolic strategies shaped by transcriptional regulation and prioritize 28 enzyme-mediated vulnerabilities, including 24 linked to existing experimental or approved drugs and 4 previously uncharacterized targets in nucleotide and lipid synthesis. They further recapitulate a ceramide-linked metabolic stress signature shared across diverse chemotherapies. Mechanistic analysis traces the effects of BRCA1 loss to transcription-factor-mediated shifts in enzyme activity, outlining regulatory routes for network-level rewiring. Beyond ovarian cancer, this framework offers a generalizable blueprint for predicting metabolic vulnerabilities, drug responses, and adaptive mechanisms across diverse cancer and metabolic disease contexts. By coupling dynamic metabolism to therapeutic prediction, it delivers actionable hypotheses for biomarker discovery, patient stratification, target prioritization, and precision metabolic medicine.


  • Open Access

    Kinetic-model-guided engineering of multiple S. cerevisiae strains improves p -coumaric acid production

    by Bharath Narayanan, Wei Jiang, Shengbao Wang, Javier Sáez-Sáez, Daniel Weilandt, Maria Masid Barcon, Viktor Hesselberg-Thomsen, Irina Borodina, Vassily Hatzimanikatis, Ljubisa Miskovic

    The use of kinetic models of metabolism in design-build-learn-test cycles is limited despite their potential to guide and accelerate the optimization of cell factories. This is primarily due to difficulties in constructing kinetic models capable of capturing the complexities of the fermentation conditions. Building on recent advances in kinetic-model-based strain design, we present the rational metabolic engineering of an S. cerevisiae strain designed to overproduce p -coumaric acid ( p -CA), an aromatic amino acid with valuable nutritional and therapeutic applications. To this end, we built nine kinetic models of an already engineered p -CA-producing strain by integrating different types of omics data and imposing physiological constraints pertinent to the strain. These nine models contained 297 mass balances involved in 303 reactions across four compartments and could reproduce the dynamic characteristics of the strain in batch fermentation simulations. We used constraint-based metabolic control analysis to generate combinatorial designs of 3 enzyme manipulations that could increase p-CA yield on glucose while ensuring that the resulting engineering strains did not deviate far from the reference phenotype. Among 39 unique designs, 10 proved robust across the phenotypic uncertainty of the models and could reliably increase p -CA yield in nonlinear simulations. We implemented these top 10 designs in a batch fermentation setting using a promoter-swapping strategy for down-regulations and plasmids for up-regulations. Eight out of the ten designs produced higher p -CA titers than the reference strain, with 19 – 32% increases at the end of fermentation. Importantly, these eight designs also maintained at least 90% of the growth of the reference strain; this indicates the importance of the phenotypic constraint. The high success rate of our in-silico designs in an experimental setting demonstrates the potential and utility of kinetic-model-based strain design. This work sets the foundation for accelerated design-build-test-learn cycles using large-scale kinetic models as a scaffold.


  • Open Access

    Host cell CRISPR genomics and modelling reveal shared metabolic vulnerabilities in the intracellular development of Plasmodium falciparum and related hemoparasites

    by Marina Maurizio, Maria Masid, Kerry Woods, Reto Caldelari, John G. Doench, Arunasalam Naguleswaran, Denis Joly, Martín González-Fernández, Jonas Zemp, Mélanie Borteele, et al.

    Parasitic diseases, particularly malaria (caused by Plasmodium falciparum) and theileriosis (caused by Theileria spp.), profoundly impact global health and the socioeconomic well-being of lower-income countries. Despite recent advances, identifying host metabolic proteins essential for these auxotrophic pathogens remains challenging. Here, we generate a novel metabolic model of human hepatocytes infected with P. falciparum and integrate it with a genome-wide CRISPR knockout screen targeting Theileria-infected cells to pinpoint shared vulnerabilities. We identify key host metabolic enzymes critical for the intracellular survival of both of these lethal hemoparasites. Remarkably, among the metabolic proteins identified by our synergistic approach, we find that host purine and heme biosynthetic enzymes are essential for the intracellular survival of P. falciparum and Theileria, while other host enzymes are only essential under certain metabolic conditions, highlighting P. falciparum’s adaptability and ability to scavenge nutrients selectively. Unexpectedly, host porphyrins emerge as being essential for both parasites. The shared vulnerabilities open new avenues for developing more effective therapies against these debilitating diseases, with the potential for broader applicability in combating apicomplexan infections.


  • Open Access

    Rational strain design with minimal phenotype perturbation

    by Bharath Narayanan, Daniel Weilandt, Maria Masid, Ljubisa Miskovic, Vassily Hatzimanikatis

    Devising genetic interventions for desired cellular phenotypes remains challenging regarding time and resources. Kinetic models can accelerate this task by simulating metabolic responses to genetic perturbations. However, exhaustive design evaluations with kinetic models are computationally impractical, especially when targeting multiple enzymes. Here, we introduce a framework for efficiently scouting the design space while respecting cellular physiological requirements. The framework employs mixed-integer linear programming and nonlinear simulations with large-scale nonlinear kinetic models to devise genetic interventions while accounting for the network effects of these perturbations. Importantly, it ensures the engineered strain’s robustness by maintaining its phenotype close to that of the reference strain. The framework, applied to improve the anthranilate production in E. coli, devises designs for experimental implementation, including eight previously experimentally validated targets. We expect this framework to play a crucial role in future design-build-test-learn cycles, significantly expediting the strain design compared to exhaustive design enumeration.


  • Open Access

    Transcriptional reprogramming by IL-2 variant generates metabolically active stem-like T cells

    by Yaquelin Ortiz-Miranda, Maria Masid, Cristina Jiménez-Luna, Galia Magela Montalvo Bereau, Tania Muller, Nicolas Rayroux, Elisabetta Cribioli, Jesús Corría-Osorio, Helen Carrasco Hope, Romain Vuillefroy de Silly, et al.

    Summary: Interleukin-2 receptor (IL-2R)-mediated intracellular signaling is a key regulator of T-cell fate decisions. While the potent signals generated by IL-2 engagement execute effector differentiation, elevated metabolic activities and rapid cellular expansion, IL-15 binding induces a stemness/memory phenotype and a quiescent metabolic state. Here, we demonstrate that weak but sustained signaling generated by a non-IL-2R α -binding variant of IL-2 (IL-2v) drive proliferation/metabolic and stemness transcriptional programs, thereby reprogramming CD8 + T cells into a hybrid ‘metabolically active stem-like state’. We further show that IL-2v-induced T cells are capable of superior engraftment, persistence, and tumor control when utilized in adoptive cell therapy. Taken together, our study highlights the ability to fine-tune cytokine engagement of cognate receptors in order to generate therapeutically relevant T-cell states and further reveals the metabolic plasticity of the T-cell memory program.


  • Open Access

    Dynamic partitioning of branched-chain amino acids-derived nitrogen supports renal cancer progression

    by Marco Sciacovelli, Aurelien Dugourd, Lorea Valcarcel Jimenez, Ming Yang, Efterpi Nikitopoulou, Ana S. H. Costa, Laura Tronci, Veronica Caraffini, Paulo Rodrigues, Christina Schmidt, et al.

    Metabolic reprogramming is critical for tumor initiation and progression. However, the exact impact of specific metabolic changes on cancer progression is poorly understood. Here, we integrate multimodal analyses of primary and metastatic clonally-related clear cell renal cancer cells (ccRCC) grown in physiological media to identify key stage-specific metabolic vulnerabilities. We show that aVHLloss-dependent reprogramming of branched-chain amino acid catabolism sustains the de novo biosynthesis of aspartate and arginine enabling tumor cells with the flexibility of partitioning the nitrogen of the amino acids depending on their needs. Importantly, we identify the epigenetic reactivation of argininosuccinate synthase (ASS1), a urea cycle enzyme suppressed in primary ccRCC, as a crucial event for metastatic renal cancer cells to acquire the capability to generate arginine, invade in vitro and metastasize in vivo. Overall, our study uncovers a mechanism of metabolic flexibility occurring during ccRCC progression, paving the way for the development of novel stage-specific therapies.


  • Open Access

    Rational strain design with minimal phenotype perturbation

    by Bharath Narayanan, Daniel Weilandt, Maria Masid, Ljubisa Miskovic, Vassily Hatzimanikatis

    Increased availability of multi-omics data has facilitated the characterization of metabolic phenotypes of cellular organisms. However, devising genetic interventions that drive cellular organisms toward the desired phenotype remains challenging in terms of time, cost, and resources. Kinetic models, in particular, hold great potential for accelerating this task since they can simulate the metabolic responses to environmental and genetic perturbations. Although the challenges in building kinetic models have been well-documented, there exists no consensus on how to use these models for strain design in a computationally tractable manner. A straightforward approach that exhaustively simulates and evaluates putative designs would be impractical, considering the intensive computational requirements when targeting multiple enzymes. We address this issue by introducing a framework to efficiently scout the space of designs while respecting the physiological requirements of the cell. The framework employs mixed-integer linear programming and nonlinear simulations with large-scale nonlinear kinetic models to devise genetic interventions in a scalable manner while accounting for the network effects of these perturbations. More importantly, the framework ensures the engineered strain’s robustness by maintaining its phenotype close to that of the reference strain. We use the framework to improve the production of anthranilate, a precursor for pharmaceutical drugs, in E. coli . The devised strategies include eight previously experimentally validated targets and also novel designs suitable for experimental implementation. As an essential part of the future design-build-test-learn cycles, we anticipate that this novel framework will enable high throughput designs and accelerated turnover in biotechnological processes.


  • Open Access

    Symbolic Kinetic Models in Python (SKiMpy): Intuitive modeling of large-scale biological kinetic models

    by Daniel R. Weilandt, Pierre Salvy, Maria Masid, Georgios Fengos, Robin Denhardt-Erikson, Zhaleh Hosseini, Vassily Hatzimanikatis

    Motivation Large-scale kinetic models are an invaluable tool to understand the dynamic and adaptive responses of biological systems. The development and application of these models have been limited by the availability of computational tools to build and analyze large-scale models efficiently. The toolbox presented here provides the means to implement, parametrize and analyze large-scale kinetic models intuitively and efficiently. Results We present a Python package (SKiMpy) bridging this gap by implementing an efficient kinetic modeling toolbox for the semiautomatic generation and analysis of large-scale kinetic models for various biological domains such as signaling, gene expression, and metabolism. Furthermore, we demonstrate how this toolbox is used to parameterize kinetic models around a steady-state reference efficiently. Finally, we show how SKiMpy can imple-ment multispecies bioreactor simulations to assess biotechnological processes. Availability The software is available as a Python 3 package on GitHub: https://github.com/EPFL-LCSB/SKiMpy, along with adequate documentation. Contact vassily.hatzimanikatis{at}epfl.ch


  • Open Access

    A genome-scale metabolic model of Saccharomyces cerevisiae that integrates expression constraints and reaction thermodynamics

    by Omid Oftadeh, Pierre Salvy, Maria Masid, Maxime Curvat, Ljubisa Miskovic, Vassily Hatzimanikatis

    Eukaryotic organisms play an important role in industrial biotechnology, from the production of fuels and commodity chemicals to therapeutic proteins. To optimize these industrial systems, a mathematical approach can be used to integrate the description of multiple biological networks into a single model for cell analysis and engineering. One of the most accurate models of biological systems include Expression and Thermodynamics FLux (ETFL), which efficiently integrates RNA and protein synthesis with traditional genome-scale metabolic models. However, ETFL is so far only applicable for E. coli. To adapt this model for Saccharomyces cerevisiae, we developed yETFL, in which we augmented the original formulation with additional considerations for biomass composition, the compartmentalized cellular expression system, and the energetic costs of biological processes. We demonstrated the ability of yETFL to predict maximum growth rate, essential genes, and the phenotype of overflow metabolism. We envision that the presented formulation can be extended to a wide range of eukaryotic organisms to the benefit of academic and industrial research.